Cargando…

Salidroside Decreases Atherosclerotic Plaque Formation in Low-Density Lipoprotein Receptor-Deficient Mice

Salidroside is isolated from Rhodiola rosea and is one of the main active components in Rhodiola species. The present study was designed to evaluate the effects of Salidroside on atherosclerotic plaque formation in high-fat diet-(HFD-) fed female LDL receptor knockout (LDLr(−/−)) mice. LDLr(−/−) mic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Bu-Chun, Li, Wei-Ming, Guo, Rong, Xu, Ya-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474264/ https://www.ncbi.nlm.nih.gov/pubmed/23093983 http://dx.doi.org/10.1155/2012/607508

Ejemplares similares

Inhibition of Lipoprotein-Associated Phospholipase A2 Ameliorates Inflammation and Decreases Atherosclerotic Plaque Formation in ApoE-Deficient Mice
por: Wang, Wen-yi, et al.
Publicado: (2011)

5-Aminolevulinic Acid Attenuates Atherosclerotic Plaque Progression in Low-Density Lipoprotein Receptor-Deficient Mice by Heme Oxygenase-1 Induction
por: Hagisawa, Kohsuke, et al.
Publicado: (2019)

Nonlinear dynamics of early atherosclerotic plaque formation may determine the efficacy of high density lipoproteins (HDL) in plaque regression
por: Chalmers, Alexander D., et al.
Publicado: (2017)

Development of Human‐Like Advanced Coronary Plaques in Low‐Density Lipoprotein Receptor Knockout Pigs and Justification for Statin Treatment Before Formation of Atherosclerotic Plaques
por: Li, Yuxin, et al.
Publicado: (2016)

Low-density lipoprotein, its susceptibility to oxidation and the role of lipoprotein-associated phospholipase A(2) and carboxyl ester lipase lipases in atherosclerotic plaque formation
por: Burchardt, Paweł, et al.
Publicado: (2013)

Systematic study of the effects of lowering low-density lipoprotein-cholesterol on regression of coronary atherosclerotic plaques using intravascular ultrasound
por: Gao, Wen-Qian, et al.
Publicado: (2014)

Tesaglitazar ameliorates non-alcoholic fatty liver disease and atherosclerosis development in diabetic low-density lipoprotein receptor-deficient mice
por: ZHANG, BU-CHUN, et al.
Publicado: (2012)

Bilirubin Prevents Atherosclerotic Lesion Formation in Low‐Density Lipoprotein Receptor‐Deficient Mice by Inhibiting Endothelial VCAM‐1 and ICAM‐1 Signaling
por: Vogel, Megan E., et al.
Publicado: (2017)

Association of Lipoprotein(a) With Atherosclerotic Plaque Progression
por: Kaiser, Yannick, et al.
Publicado: (2022)

Cysteamine Decreases Low‐Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low‐Density Lipoprotein Receptor–Deficient Mice
por: Ahmad, Feroz, et al.
Publicado: (2021)

Correlation between of small dense low‐density lipoprotein cholesterol with acute cerebral infarction and carotid atherosclerotic plaque stability
por: QiaoZhen, Xue, et al.
Publicado: (2019)

Degradation of Glycocalyx and Multiple Manifestations of Endothelial Dysfunction Coincide in the Early Phase of Endothelial Dysfunction Before Atherosclerotic Plaque Development in Apolipoprotein E/Low‐Density Lipoprotein Receptor‐Deficient Mice
por: Bar, Anna, et al.
Publicado: (2019)

A Statin-Loaded Reconstituted High-Density Lipoprotein Nanoparticle Inhibits Atherosclerotic Plaque Inflammation
por: Duivenvoorden, Raphaël, et al.
Publicado: (2014)

Modulating the Gut Microbiota Improves Glucose Tolerance, Lipoprotein Profile and Atherosclerotic Plaque Development in ApoE-Deficient Mice
por: Rune, Ida, et al.
Publicado: (2016)

Xyloketal B Attenuates Atherosclerotic Plaque Formation and Endothelial Dysfunction in Apolipoprotein E Deficient Mice
por: Zhao, Li-Yan, et al.
Publicado: (2015)

Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases
por: Ivanova, Ekaterina A., et al.
Publicado: (2017)

Myeloperoxidase-oxidized high density lipoprotein impairs atherosclerotic plaque stability by inhibiting smooth muscle cell migration
por: Zhou, Boda, et al.
Publicado: (2017)

Modulating Lipoprotein Transcellular Transport and Atherosclerotic Plaque Formation in ApoE(–/–) Mice via Nanoformulated Lipid–Methotrexate Conjugates
por: Di Francesco, Valentina, et al.
Publicado: (2020)

Visfatin Destabilizes Atherosclerotic Plaques in Apolipoprotein E–Deficient Mice
por: Li, Bo, et al.
Publicado: (2016)

Upregulation of miR-142-5p in atherosclerotic plaques and regulation of oxidized low-density lipoprotein-induced apoptosis in macrophages
por: XU, RUIJIN, et al.
Publicado: (2015)

Salidroside downregulates microRNA-133a and inhibits endothelial cell apoptosis induced by oxidized low-density lipoprotein
por: Zhang, Yongjie, et al.
Publicado: (2020)

Relationship between subclasses low-density lipoprotein and carotid plaque
por: Pan, Zhanhai, et al.
Publicado: (2022)

Low Density Lipoprotein-Cholesterol/High Density Lipoprotein-Cholesterol Ratio Predicts Plaque Vulnerability in Patients With Stable Angina
por: Kim, Jeong Hun, et al.
Publicado: (2012)

Salidroside attenuates oxidized low-density lipoprotein-induced endothelial cell injury via promotion of the AMPK/SIRT1 pathway
por: Zhao, Dongming, et al.
Publicado: (2019)

Salidroside-Mediated Autophagic Targeting of Active Src and Caveolin-1 Suppresses Low-Density Lipoprotein Transcytosis across Endothelial Cells
por: Bai, Xiangli, et al.
Publicado: (2020)

Impairing Eukaryotic Elongation Factor 2 Kinase Activity Decreases Atherosclerotic Plaque Formation
por: Zhang, Peng, et al.
Publicado: (2014)

Expression of Chitotriosidase in Macrophages Modulates Atherosclerotic Plaque Formation in Hyperlipidemic Mice
por: Yap, Jonathan, et al.
Publicado: (2020)

Weight Gain After Smoking Cessation and Atherosclerotic Low-Density Lipoprotein Marker
por: Iida, Mami
Publicado: (2016)

Association between circulating oxidized low-density lipoprotein and atherosclerotic cardiovascular disease
por: Gao, Shen, et al.
Publicado: (2017)

Does low-density lipoprotein fully explain atherosclerotic risk in familial hypercholesterolemia?
por: Clarke, Shoa L.
Publicado: (2023)

Neonatal Subcutaneous BCG Vaccination Decreases Atherosclerotic Plaque Number and Plaque Macrophage Content in ApoE(−/−) Mice
por: Bekkering, Siroon, et al.
Publicado: (2022)

Dystrophin deficiency reduces atherosclerotic plaque development in ApoE-null mice
por: Shami, Annelie, et al.
Publicado: (2015)

IL‐23R Deficiency Does Not Impact Atherosclerotic Plaque Development in Mice
por: Engelbertsen, Daniel, et al.
Publicado: (2018)

Deficiency of Adipocyte IKKβ Affects Atherosclerotic Plaque Vulnerability in Obese LDLR Deficient Mice
por: Lu, Weiwei, et al.
Publicado: (2019)

Association of Lipoprotein-Associated Phospholipase A(2) with Characteristics of Vulnerable Coronary Atherosclerotic Plaques
por: Liu, Yu-Sheng, et al.
Publicado: (2011)

Native low density lipoprotein promotes lipid raft formation in macrophages
por: SONG, JIAN, et al.
Publicado: (2016)

Capsanthin Inhibits Atherosclerotic Plaque Formation and Vascular Inflammation in ApoE(−/−) Mice
por: Kim, Sungmin, et al.
Publicado: (2022)

The Microbiota Promotes Arterial Thrombosis in Low-Density Lipoprotein Receptor-Deficient Mice
por: Kiouptsi, Klytaimnistra, et al.
Publicado: (2019)

Myeloid β-Catenin Deficiency Exacerbates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice
por: Wang, Fang, et al.
Publicado: (2018)

Residual Risk of Atherosclerotic Cardiovascular Events in Relation to Reductions in Very‐Low‐Density Lipoproteins
por: Lawler, Patrick R., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_d46pcmuuan6n7sm3su5fvnbs9q